• Adil M Alshahrani, Omayma S Bakheet, Mohammed H Makkawi, and Sultan Z Alasmari.
• From the Department of Laboratory and Blood Bank (Adil, Omayma), Aseer Central Hospital; and from the Department of Clinical Laboratory Sciences (Mohammed, Sultan), Faculty of Applied Medical Sciences, King Khalid University, Abha, Kingdom of Saudi Arabia.
• Saudi Med J. 2024 Mar 1; 45 (3): 295306295-306.

ObjectivesTo determine the prevalence of leukemia in the Aseer region of Saudi Arabia and the importance of hematological, biochemical and coagulation profiles for leukemic patients in the context of disease management.MethodsThis retrospective study comprised 210 patients between 2012 and 2022 who had been diagnosed with leukemia at different ages. The multiple unpaired t-test was used to compare leukemic patients with control samples, which consisted of healthy individuals, and p<0.05 was taken as significant. The data was compiled from Aseer Central Hospital in the Aseer region and collected through peripheral blood smear and bone marrow biopsy (2012-2017) or by flow cytometry (2018-2022), according to the hospital information system and registry data.ResultsOf the total 210 leukemic patients (61.4% males and 38.6% females), 104 cases (2012-2017) were diagnosed based on peripheral blood smear and bone marrow biopsy, and 106 cases (2018-2022) based on flow cytometry. Fifteen subtypes of leukemia were identified, with chronic myeloid leukemia being the most common (34.2%), followed by acute myeloid leukemia (17.6%), chronic lymphoblastic leukemia (11.9%), and B-cell acute lymphoid leukemia (9.5%). Other rare cases were also found.ConclusionOf the 210 leukemia cases diagnosed in the Aseer region between 2012-2022, the most common subtype was chronic myeloid leukemia, followed by acute myeloid leukemia. In all leukemia subtypes, distinctive significant changes were observed in hematological parameters, biochemical parameters, and coagulation profiles.Copyright: © Saudi Medical Journal.

15 keywords...

hide…